Healthcare professional resources for asthma
These asthma resources are for healthcare professionals working in both primary and secondary care settings. See the latest Summary of Product Characteristics (SmPC) for SPIRIVA® Respimat® in asthma
Resources to share and discuss with patients can be found here.
SPIRIVA® Respimat® is approved for use in adult asthma patients in the EU, Japan, the USA and many other countries. The label varies by country. Please refer to the local product information.
Global Initiative for Asthma (GINA) works with the healthcare community to reduce asthma prevalence, morbidity and mortality.
Every year the GINA science committee reviews published research on asthma management and prevention and, if appropriate, updates recommendations in GINA documents. Read the latest recommendations...
An infographic and accompanying short video explores the global picture around the burden of asthma and the lack of symptom control that many patients continue to experience.
The page will connect you to news items on AsthmaXchange where you can keep up-to-date with recent insights into asthma treatment and management as well as commentaries from congresses around the world.